(6-258) Analysis of Potential Pharmacokinetic CYP3A4 Drug Interactions Resulting in Kidney Injury Reported in FDA Adverse Event Reporting System and Canada Vigilance Adverse Reaction Online Database

Tuesday, December 6, 2022

10:45 AM – 11:45 AM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Safety/Quality

Co-Author(s): Sandra Kane-Gill, Matthew Gray, Jacob Murawski, Britney Stottlemyer

Primary Author(s)

Feiran Liang
Pharmacy Student
The University of Pittsburgh, School of Pharmacy, Pennsylvania